Start with the clinical question.
Browse cardiac ischemia, resuscitation, severe anemia, trauma, surgery, critical care and oncology evidence.
Browse directions →Explore human clinical publications, reviews and translational studies by therapeutic direction, while keeping human evidence clearly separated from animal, veterinary and analytical research.
Select a therapeutic direction to open matching publications.
Counts are catalogue assignments, not conclusions about efficacy, safety or regulatory status.
Human clinical, preclinical, analytical, review and pending-classification records remain separately labelled. A publication may support scientific context without establishing a clinical claim.
Single-source records remain flagged until verified against an original identifier or full text.
Relevant animal and veterinary studies are retained because they may inform human development, dosing, physiology, safety or regulatory planning. They are never presented as human clinical evidence.
Open translational preclinical evidence →This separation is essential: evidence can support development without being equivalent to clinical proof, regulatory approval or a recommendation for use.
Browse cardiac ischemia, resuscitation, severe anemia, trauma, surgery, critical care and oncology evidence.
Browse directions →Review the HBOC-201 expanded-access study record, FDA pathway and IND requirements without confusing access with marketing approval.
FDA US Expanded Access →Search 72 indexed author institutions and 96 normalized journal labels, then open available PubMed, DOI and original publication links.
Search the evidence →This section is a structured evidence map. Publication inclusion does not establish efficacy, regulatory approval or a clinical recommendation. Historical HBOC, HBOC-201 and Hemopure terminology is retained for accurate scientific discovery.